CFLAR and ischemic stroke: In summary, this study found that piperlongumine has the function of anti-ischemic stroke injury, and proposed for the first time that piperlongumine can exert anti-cerebral microvascular endothelial cell apoptosis by binding to proteins encoded by Actb and Cflar genes, thereby reducing ischemic stroke injury and promoting recovery.